ESI To File Virtual Electrogram Coronary Mapping Device 510(k) This Quarter
This article was originally published in The Gray Sheet
Executive Summary
Endocardial Solutions, Inc. (ESI) expects to obtain 510(k) approval by year-end for use of the Ensite 3000 catheter system in mapping the right coronary atrium, President and CEO James Bullock told investors April 27 at the Volpe Brown Whelan & Co. health care conference in New York City.